Risk Of Developing Liver Cancer After HCV Treatment

Monday, July 24, 2017

The Financial Case for Action on Liver Disease - Escalating costs of alcohol misuse, obesity and viral hepatitis JULY 2017

The Foundation for Liver Research

Monday 17th July 2017
The Lancet Commission into Liver Disease in the UK has today published 'The Financial Case for Action on Liver Disease'

In this paper the Foundation for Liver Research seeks to make the financial case for concerted preventative action through public health measures to tackle the 3 main causes of liver disease: alcohol misuse, obesity and viral hepatitis. The paper summarises the escalating financial costs to the health and care system as well as the wider societal costs related to the 3 lifestyle-related factors.






No comments:

Post a Comment